Latest Distributions News

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.

South32 has exceeded its FY25 production targets, driven by a 20% increase in copper output and significant progress at its Hermosa project, while streamlining its portfolio through key divestments.

Patronus Resources has validated the Thunderball uranium deposit as a high-grade asset through a comprehensive re-assay program, with extensional drilling now underway to explore its growth potential in the Northern Territory’s Pine Creek region.

Peregrine Gold Limited has announced a major discovery of a high-grade Channel Iron Deposit spanning over 7.7km near key BHP iron ore operations in Western Australia. Initial assays reveal iron grades averaging 57%, highlighting significant potential for the Newman Gold Project.

Euroz Hartleys Group Limited has secured shareholder approval for a $63 million capital return, marking a significant milestone in its long history of shareholder distributions.

Strickland Metals plans a capital return by distributing 1.2 billion Gateway Convertible Preference Shares to its shareholders, significantly reducing its stake and reshaping ownership. The move awaits shareholder approval and hinges on conditions tied to an asset sale agreement.

Aldoro Resources has confirmed that mineralisation at its Kameelburg project in Namibia now extends 1,350 meters east-west, with high-grade assays from recent drilling underpinning the upcoming maiden resource estimate.

McPherson’s Limited anticipates FY25 revenue around $139 million with a strong second-half EBITDA rebound, while its strategic shift to third-party wholesalers sets the stage for significant EBIT gains in FY26.

Capral Limited has agreed to acquire Perth-based aluminium systems distributor Comsupply Ltd, aiming to strengthen its foothold in Western Australia’s building systems market.

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

360 Capital Mortgage REIT has successfully raised $6.4 million through an additional placement of over one million new units, aiming to expand its mortgage loan portfolio and enhance trading liquidity.